Hemarina

company

About

Hemarina is a biotechnology company focused on the research and development of oxygen carriers for medical applications.

  • 11 - 50

Details

Last Funding Type
Series C
Industries
Biotechnology,Medical Device,Product Research
Founded date
Mar 1, 2007
Number Of Employee
11 - 50
Operating Status
Active

Hemarina SA. is a privately held biotechnology company focused on the research, and development of oxygen-carriers for medical applications.
Dr. Franck Zal, an expert in the field of invertebrate hemoglobin and oxygen transport, founded Hemarina after having spent more than fourteen years in academic research centers (CNRS, University of California at Santa Barbara USA and University of Antwerpen, Belgium) studying the relationships between the structure and function of invertebrate respiratory pigment (annelid’s extracellular hemoglobin and crustacean hemocyanin). The discoveries arising from his research on extracellular hemoglobin coming from marine invertebrates and their effective oxygen transport system have been patented and published in numerous scientific journals and form the basis of Hemarina’s technologies.

Hemarina’s approach to the development of oxygen transport agents is based on the observation of marine worms colonizing extreme environments and the study of their respiratory adaptations.

Hemarina’s lead product, HbAm, is designed to deliver oxygen effectively and efficiently to tissues at risk of oxygen deprivation. Hemarina has already a passed panel of strong proof of concepts obtained during preclinical trials.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$4.79M
Hemarina has raised a total of $4.79M in funding over 2 rounds. Their latest funding was raised on Mar 15, 2017 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 15, 2017 Series C 2 Detail
Jul 2, 2010 Series B $3.70M 1 Inserm Transfert Initiative Detail
Feb 16, 2009 Series A $1.09M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Hemarina is funded by 3 investors. Inserm Transfert Initiative and Finistère Angels are the most recent investors.
Investor Name Lead Investor Funding Round
Inserm Transfert Initiative Yes Series B
Finistère Angels Series C
Armor Angels Series C